日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparing the pharmacokinetics of adalimumab originator and biosimilar product in patients with Inflammatory bowel disease or autoimmune disease

比较阿达木单抗原研药和生物类似药在炎症性肠病或自身免疫性疾病患者中的药代动力学

Drweesh, Hadeel; Alotaibi, Amal; Alqassim, Hussain Abdalghani; Eid, Mohammed Mustafa; Emsaad, Shaimaa Abdulhadi; Saad, Mohamed Omar; Higazy, Alya Salah; Alturaiki, Abdulrahman; Almutairi, Fares; Alhussain, Abdulsattar; Assiri, Abdulmohsen; Alkofide, Hadeel; Alruthia, Yazeed; Albassam, Ahmed; Alsultan, Abdullah

Evolution of Computerized Provider Order Entry Documentation at a Leading Tertiary Care Referral Center in Riyadh

利雅得一家领先的三级医疗转诊中心计算机化医嘱录入文档的演变

Alanazi, Hanan Sabet; Alruthia, Yazed

Creating A Multi-Criteria Decision Analysis Tool to Enhance Value-Based Purchasing of Generic and Biosimilar Medications in Saudi Arabia: A Pilot Study

构建多准则决策分析工具以提升沙特阿拉伯仿制药和生物类似药的价值导向采购:一项试点研究

Alruthia, Yazed; Alhajri, Horiyah; Almohammed, Omar A; Balkhi, Bander; Alsaqa'aby, Mai F; Almuqbil, Mohammed A; Al-Abdulkarim, Hana A; Almutairi, Abdulaali R

Healthcare systems and health economics in GCC countries: informing decision-makers from the perspective of the Gulf health economics association

海湾合作委员会国家的医疗保健系统和卫生经济学:从海湾卫生经济学协会的角度为决策者提供信息

AlRuthia, Yazed; Aldallal, Sara; Al-Abdulkarim, Hana A; Al-Jedai, Ahmed; Almudaiheem, Hajer; Hamad, Anas; Elmusharaf, Khalifa; Saadi, Mouza; Al Awar, Hamda; Al Sabbah, Haleama; Alghnam, Suliman; Al Ghamdi, Mohamed; Monshi, Sarah S; AlAgil, Nada; Al Khalifa, Mohamed Ebrahim; Abdulkarim, Qasim; Abdulkarim, Sawsan; Jawad, Huda; Al-Sabahi, Sultana; Al Kindi, Asiya; Wani, Said; Alibrahim, Abdullah

Driving the future of value-based healthcare in the Gulf Cooperation Council: a roadmap for achieving sustainable access to specialty pharmaceuticals

推动海湾合作委员会以价值为导向的医疗保健的未来:实现可持续获取专科药品的路线图

Hamad, Anas; Al-Jedai, Ahmed; Ojeil, Rita; Al-Jazairi, Abdulrazaq Sheikh; AlAssy, Adel; AlRuthia, Yazed S; Al Naeem, Waiel; Almudaiheem, Hajer; Alsaadi, Mouza; Alagil, Nada; Wahba, Lina; Marghalani, Abdulmohsin; Al Hashar, Amna; AlShehry, Abdullah O; Alblooshi, Sana; Alharbi, Ibtisam; Moukarzel, Marleine Bejjani; Albalushi, Sara; El-Sheashaey, Ahmed M; Aseeri, Mohammed A; Alenezy, Farid; Adheir, Fathea; Aloumi, Abdulrahman; Alnoaimi, Rehab; Alnaqbi, Khalid A

Sterile injectable products shortage in Saudi Arabia: a survey-based cross-sectional study

沙特阿拉伯无菌注射剂短缺:一项基于调查的横断面研究

Alzhrani, Riyad F; Alrasheed, Marwan; Alzammam, Ibrahim; Alruthia, Yazed

Addressing Gabapentinoids' Access Challenges in Saudi Arabia Under New Prescription Regulations: An Expert View

专家观点:沙特阿拉伯新处方法规下加巴喷丁类药物获取挑战的应对之道

Aldossari, Khaled K; AlRuthia, Yazed; Amir, Ashraf; Alshurem, Mohammed; Elbadawi, Hussein; Kaki, Abdullah

Medical and Financial Consequences of Using PCSK9 Inhibitors for Managing Hypercholesterolemia in Saudi Arabia: A Historical Cohort Study

在沙特阿拉伯使用PCSK9抑制剂治疗高胆固醇血症的医疗和经济后果:一项历史性队列研究

AlRuthia, Yazed; Almutairi, Khlood Khaled; Aljammaz, Norah Abdulaziz; Alsuwayegh, Aseel; Alanazi, Miteb A; AlSulaiman, Rasha Fahad; Alfaori, Tareq Majed; Alabdan, Numan

The Direct Medical Costs of Sickle Cell Disease in Saudi Arabia: Insights from a Single Center Study

沙特阿拉伯镰状细胞病直接医疗成本:来自单中心研究的启示

AlRuthia, Yazed

Cost-Consequence Analysis of Semaglutide vs. Liraglutide for Managing Obese Prediabetic and Diabetic Patients in Saudi Arabia: A Single-Center Study

沙特阿拉伯单中心研究:索玛鲁肽与利拉鲁肽治疗肥胖糖尿病前期和糖尿病患者的成本效益分析

Bawazeer, Najla; Bin Ganzal, Seham; Al-Hasinah, Huda F; Alruthia, Yazed